BRIEF-Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit Agreement - SEC Filing

Reuters02-03 19:16

Feb 3 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O:

AMNEAL PHARMA - ON FEB 2ND, CO ENTERS AMENDMENT NO. 2 TO TERM LOAN CREDIT AGREEMENT - SEC FILING
AMNEAL PHARMA: CONSENTING LENDERS CONVERTED EXISTING TERM LOANS INTO NEW TERM LOANS WITH AN AMOUNT OF $1.96 BILLION-SEC FILING
AMNEAL PHARMA: INCURRED NEW TERM LOAN WITH AN AMOUNT OF $134.7 MILLION- SEC FILING

Source text: [ID:n0001628280-26-004738]

Further company coverage: AMRX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2608205508?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-03 19:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2608205508","market":"fut","top_or_hot":-1,"title":"BRIEF-Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit Agreement - SEC Filing","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit Agreement - SEC Filing</title></head><body><p><span>Feb 3 (Reuters)</span><span> - </span>Amneal Pharmaceuticals Inc <span>AMRX.O</span>:</p><ul><li><p>AMNEAL PHARMA - ON FEB 2ND, CO ENTERS AMENDMENT NO. 2 TO TERM LOAN CREDIT AGREEMENT - SEC FILING</p></li><li><p>AMNEAL PHARMA: CONSENTING LENDERS CONVERTED EXISTING TERM LOANS INTO NEW TERM LOANS WITH AN AMOUNT OF $1.96 BILLION-SEC FILING</p></li><li><p>AMNEAL PHARMA: INCURRED NEW TERM LOAN WITH AN AMOUNT OF $134.7 MILLION- SEC FILING</p></li></ul><p>Source text: [ID:n0001628280-26-004738]</p><p>Further company coverage: <span>AMRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit Agreement - SEC Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit Agreement - SEC Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-03 19:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit Agreement - SEC Filing</title></head><body><p><span>Feb 3 (Reuters)</span><span> - </span>Amneal Pharmaceuticals Inc <span>AMRX.O</span>:</p><ul><li><p>AMNEAL PHARMA - ON FEB 2ND, CO ENTERS AMENDMENT NO. 2 TO TERM LOAN CREDIT AGREEMENT - SEC FILING</p></li><li><p>AMNEAL PHARMA: CONSENTING LENDERS CONVERTED EXISTING TERM LOANS INTO NEW TERM LOANS WITH AN AMOUNT OF $1.96 BILLION-SEC FILING</p></li><li><p>AMNEAL PHARMA: INCURRED NEW TERM LOAN WITH AN AMOUNT OF $134.7 MILLION- SEC FILING</p></li></ul><p>Source text: [ID:n0001628280-26-004738]</p><p>Further company coverage: <span>AMRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ0DA:1","article_id":"2608205508","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2608205508","pubTimestamp":1770117368,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit Agreement - SEC FilingFeb 3  - Amneal Pharmaceuticals Inc AMRX.O:AMNEAL PHARMA - ON FEB 2ND, CO ENTERS AMENDMENT NO. 2 TO TERM LOAN CREDIT AGREEMENT - SEC FILINGAMNEAL PHARMA: CONSENTING LENDERS CONVERTED EXISTING TERM LOANS INTO NEW TERM LOANS WITH AN AMOUNT OF $1.96 BILLION-SEC FILINGAMNEAL PHARMA: INCURRED NEW TERM LOAN WITH AN AMOUNT OF $134.7 MILLION- SEC FILINGSource text: [ID:n0001628280-26-004738]Further company coverage: AMRX.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","AMRX":"Amneal Pharmaceuticals, Inc."},"translate_title":"简报-Amneal Pharma表示，2月2日，Co进入定期贷款信贷协议第2号修正案-向SEC提交文件","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMRX":0.9},"content_text":"BRIEF-Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit Agreement - SEC FilingFeb 3 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O:AMNEAL PHARMA - ON FEB 2ND, CO ENTERS AMENDMENT NO. 2 TO TERM LOAN CREDIT AGREEMENT - SEC FILINGAMNEAL PHARMA: CONSENTING LENDERS CONVERTED EXISTING TERM LOANS INTO NEW TERM LOANS WITH AN AMOUNT OF $1.96 BILLION-SEC FILINGAMNEAL PHARMA: INCURRED NEW TERM LOAN WITH AN AMOUNT OF $134.7 MILLION- SEC FILINGSource text: [ID:n0001628280-26-004738]Further company coverage: AMRX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2608205508","isCrawlerRequest":true}